Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by biorunon Aug 31, 2022 2:57pm
148 Views
Post# 34933271

RE:RE:RE:RE:RE:RE:RE:New patent

RE:RE:RE:RE:RE:RE:RE:New patentoh brother, you again. lmfao. 

However, every time you show up, its time for another run, which does make me happy. poking at the company to shake 5000 shares from the tree.

for Howard, I am sure he is a great doctor, but replacing him with a CEO who has professional business development experience within the big pharma world would certainly be a good step in the right direction. he gets credit for putting in some key people and bringing home the Abbvie deal, maintaining momentum on a shoestring, but certainly he does not seem to have the time to dedicate to both the business and the investment community which are both necessary for growth. I want a CEO who is on the phone with investors at least 6 of the 12 hours of the workday, and on the road presenting at conferences in front of 2000 people or more, and preferably one qui peut parler francais aussi.

as for resources, putting in a new CEO without the necessary resources to make some calculated manoevres is pointless. If they do nominate someone, that signals to me revenue and growth visibility is quite real/probable. 

HCD, its time you declare YOUR interest. I sense you are in and out of this stock still and don't say when. Your system was probably triggered by the small peak in volume yesterday and caused you to have another look. Why else would you troll around. 




<< Previous
Bullboard Posts
Next >>